Femasys Inc. (NASDAQ:FEMY) Short Interest Up 70.1% in May

Femasys Inc. (NASDAQ:FEMY) saw a large increase in short interest in the month of May. As of May 29th, there was short interest totaling 3,326,404 shares, an increase of 70.1% from the May 14th total of 1,955,435 shares. Approximately 6.0% of the company’s shares are short sold. Based on an average daily volume of 3,901,852 shares, the days-to-cover ratio is currently 0.9 days.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the company. Wall Street Zen upgraded Femasys to a “hold” rating in a report on Saturday. Lake Street Capital assumed coverage on shares of Femasys in a research report on Tuesday, March 3rd. They issued a “buy” rating and a $30.00 price target on the stock. Finally, Weiss Ratings raised shares of Femasys from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, June 3rd. Three equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Femasys currently has an average rating of “Moderate Buy” and a consensus price target of $106.67.

Hedge Funds Weigh In On Femasys

Several hedge funds have recently made changes to their positions in FEMY. Jane Street Group LLC bought a new stake in shares of Femasys in the second quarter worth $82,000. Osaic Holdings Inc. bought a new stake in Femasys during the 2nd quarter worth about $45,000. Geode Capital Management LLC boosted its stake in shares of Femasys by 50.8% during the 4th quarter. Geode Capital Management LLC now owns 389,280 shares of the company’s stock worth $224,000 after buying an additional 131,052 shares during the last quarter. Kovack Advisors Inc. bought a new position in shares of Femasys in the 4th quarter valued at about $27,000. Finally, Banco BTG Pactual S.A. acquired a new stake in shares of Femasys in the fourth quarter valued at about $88,000. 65.27% of the stock is owned by institutional investors.

Femasys Stock Up 13.6%

FEMY traded up $0.52 during trading on Wednesday, reaching $4.36. The company had a trading volume of 42,392 shares, compared to its average volume of 49,747. The company has a market cap of $13.17 million, a P/E ratio of -0.81 and a beta of -2.23. Femasys has a 12 month low of $3.77 and a 12 month high of $22.20. The company has a debt-to-equity ratio of 0.53, a current ratio of 3.91 and a quick ratio of 1.98. The business’s fifty day moving average price is $7.41 and its 200 day moving average price is $10.68.

Femasys (NASDAQ:FEMY) last posted its quarterly earnings data on Friday, May 8th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of ($1.33) by $1.43. Femasys had a negative net margin of 521.97% and a negative return on equity of 258.08%. The business had revenue of $0.42 million for the quarter, compared to analysts’ expectations of $0.77 million.

Femasys Company Profile

Femasys International, Inc is a medical device company focused on the research, development and commercialization of innovative technologies for interventional women’s health applications. The company’s core activities center on creating minimally invasive diagnostic and therapeutic products designed to address uterine cavity evaluation and treatment and to improve outcomes in gynecological care.

The company’s flagship product, the FemVue® hydrosonography system, is a single-use catheter-based device that enhances visualization of the uterine cavity through saline infusion sonography.